Alpha Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-19,238
| Closed | -$1.61M | – | 112 |
|
|
2021
Q2 | $1.61M | Buy |
19,238
+978
| +5% | +$81.6K | 0.38% | 68 |
|
|
2021
Q1 | $1.38M | Buy |
18,260
+581
| +3% | +$43.9K | 0.35% | 74 |
|
|
2020
Q4 | $1.55M | Buy |
17,679
+413
| +2% | +$36.2K | 0.39% | 69 |
|
|
2020
Q3 | $1.31M | Sell |
17,266
-721
| -4% | -$54.9K | 0.38% | 70 |
|
|
2020
Q2 | $2.22M | Sell |
17,987
-459
| -2% | -$56.6K | 0.76% | 48 |
|
|
2020
Q1 | $1.56M | Buy |
18,446
+650
| +4% | +$54.9K | 0.69% | 50 |
|
|
2019
Q4 | $1.51M | Sell |
17,796
-624
| -3% | -$52.8K | 0.55% | 62 |
|
|
2019
Q3 | $1.24M | Buy |
18,420
+1,036
| +6% | +$69.9K | 0.46% | 72 |
|
|
2019
Q2 | $1.49M | Buy |
+17,384
| New | +$1.49M | 0.56% | 60 |
|
|
2016
Q1 | – | Sell |
-2,175
| Closed | -$228K | – | 75 |
|
|
2015
Q4 | $228K | Sell |
2,175
-25
| -1% | -$2.62K | 0.18% | 64 |
|
|
2015
Q3 | $232K | Hold |
2,200
| – | – | 0.21% | 56 |
|
|
2015
Q2 | $301K | Sell |
2,200
-3,487
| -61% | -$477K | 0.23% | 61 |
|
|
2015
Q1 | $514K | Hold |
5,687
| – | – | 0.36% | 57 |
|
|
2014
Q4 | $514K | Hold |
5,687
| – | – | 0.36% | 57 |
|
|
2014
Q3 | $410K | Buy |
5,687
+575
| +11% | +$41.5K | 0.32% | 54 |
|
|
2014
Q2 | $318K | Buy |
5,112
+787
| +18% | +$49K | 0.23% | 63 |
|
|
2014
Q1 | $295K | Buy |
+4,325
| New | +$295K | 0.23% | 64 |
|